Generosity Heals

MIAMI, FL – January 10, 2023 – Baptist Health Foundation announced today that BMI, an international insurance company based in Miami, has made a $2 million donation in support of Baptist Health’s Digital Patient Smart TV and Engagement system.

MIAMI, FL – September 6, 2022 – Healthcare organizations across the U.S., including Baptist Health South Florida, join together each year on September 7 to honor National Grateful Patient Day. This is the day when patients – from those who have overcome devastating illnesses to others who just want to show their appreciation – tell their stories and express their gratitude to the dedicated healthcare professionals who have made a difference in their lives.

MIAMI, FL – August 9, 2022 – Miami Cancer Institute, part of Baptist Health South Florida, has spearheaded the creation of the Global Bladder Cancer Consortium (GBCC), an international collaboration between the world’s top experts in bladder cancer, led by Murugesan Manoharan, M.D., leader of the GBCC and chief of urologic oncologic surgery at Miami Cancer Institute. Among the GBCC’s priorities are creating a large and diverse patient database, launching clinical trials at multiple sites throughout the world and sharing information ― all initiatives that will impact patient outcomes and improve care for those with bladder cancer.

MIAMI, FL – July 28, 2022 – Baptist Health Foundation announced that IVFMD, a fertility medicine practice founded by Juergen Eisermann, M.D., has made a $1 million gift to Baptist Health Foundation in support of South Miami Hospital, part of Baptist Health. The gift will help fund several programs at the hospital, primarily supporting women, infants and children.

MIAMI, FL – June 29, 2022 – Baptist Health Foundation announced today that prominent Miami philanthropists Trish and Dan Bell have made a $2 million gift to Baptist Health Foundation in support of the Cancer Health Equity Research Center (CHERC) at Baptist Health Miami Cancer Institute. The gift will assist the CHERC in increasing the enrollment of medically underserved populations in clinical cancer trials in order to address disparities in health outcomes among minority groups.